近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan Bennett, H., Waser, N., Johnston, K., Kao, J-H., Lim, Y-S., Duan, Z., Lee, Y-J., Wei, L., Chen, C-J., Sievert, W., Yuan, Y. & Li, H. 2015 In : Hepatology International. 9, 3, p. 378 - 390 13 p. Research - peer-review › Article Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study Sievert, W. & 33 others 2015 In : Gut. 64, 6, p. 948 - 956 9 p. Research - peer-review › Article Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with prev Sievert, W. & 21 others 2015 In : Lancet. 385, 9973, p. 1075 - 1086 12 p. Research - peer-review › Article Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection Sievert, W. & 25 others 2015 In : Jama-Journal of the American Medical Association. 313, 17, p. 1728 - 1735 8 p. Research - peer-review › Article HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths Sievert, W. 2015 In : Medical Journal of Australia. 202, 9, p. 479 - 479 1 p.